Research and development of Zika virus vaccines

Brian E. Dawes, Claire A. Smalley, Bethany L. Tiner, David Beasley, Gregg Milligan, Lisa M. Reece, Joachim Hombach, Alan Barrett

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Zika virus (ZIKV) is a member of the family Flaviviridae, genus Flavivirus, and is transmitted by Aedes sp. mosquitoes. There are three genetic lineages of ZIKV: the East African, West African and Asian lineages. Until recently, Zika fever (ZF) has normally been considered a rare, mild febrile disease, but reports since 2012 have shown potentially severe complications associated with ZIKV infection, including microcephaly and Guillain-Barré syndrome. There are no licensed vaccines for ZIKV; however, many vaccine platforms/approaches that have been utilised for other flavivirus vaccines are being applied to ZIKV. Given the current outbreak of ZIKV in the Americas with its associated risks to pregnancy, we summarise what is known about the virus, how knowledge of currently licensed flavivirus vaccines can be applied to ZIKV vaccine development and the assessments of potential challenges for ZIKV vaccine testing and evaluation.

Original languageEnglish (US)
Article number16007
Journalnpj Vaccines
Volume1
DOIs
StatePublished - Jul 28 2016

Fingerprint

Vaccines
Flavivirus
Research
Flaviviridae
Microcephaly
Aedes
Zika Virus
Culicidae
Disease Outbreaks
Fever
Viruses
Pregnancy
Zika Virus Infection

ASJC Scopus subject areas

  • Pharmacology
  • Infectious Diseases
  • Immunology
  • Pharmacology (medical)

Cite this

Research and development of Zika virus vaccines. / Dawes, Brian E.; Smalley, Claire A.; Tiner, Bethany L.; Beasley, David; Milligan, Gregg; Reece, Lisa M.; Hombach, Joachim; Barrett, Alan.

In: npj Vaccines, Vol. 1, 16007, 28.07.2016.

Research output: Contribution to journalReview article

Dawes, Brian E. ; Smalley, Claire A. ; Tiner, Bethany L. ; Beasley, David ; Milligan, Gregg ; Reece, Lisa M. ; Hombach, Joachim ; Barrett, Alan. / Research and development of Zika virus vaccines. In: npj Vaccines. 2016 ; Vol. 1.
@article{a13204242bd7465982cde7b378687481,
title = "Research and development of Zika virus vaccines",
abstract = "Zika virus (ZIKV) is a member of the family Flaviviridae, genus Flavivirus, and is transmitted by Aedes sp. mosquitoes. There are three genetic lineages of ZIKV: the East African, West African and Asian lineages. Until recently, Zika fever (ZF) has normally been considered a rare, mild febrile disease, but reports since 2012 have shown potentially severe complications associated with ZIKV infection, including microcephaly and Guillain-Barr{\'e} syndrome. There are no licensed vaccines for ZIKV; however, many vaccine platforms/approaches that have been utilised for other flavivirus vaccines are being applied to ZIKV. Given the current outbreak of ZIKV in the Americas with its associated risks to pregnancy, we summarise what is known about the virus, how knowledge of currently licensed flavivirus vaccines can be applied to ZIKV vaccine development and the assessments of potential challenges for ZIKV vaccine testing and evaluation.",
author = "Dawes, {Brian E.} and Smalley, {Claire A.} and Tiner, {Bethany L.} and David Beasley and Gregg Milligan and Reece, {Lisa M.} and Joachim Hombach and Alan Barrett",
year = "2016",
month = "7",
day = "28",
doi = "10.1038/npjvaccines.2016.7",
language = "English (US)",
volume = "1",
journal = "npj Vaccines",
issn = "2059-0105",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Research and development of Zika virus vaccines

AU - Dawes, Brian E.

AU - Smalley, Claire A.

AU - Tiner, Bethany L.

AU - Beasley, David

AU - Milligan, Gregg

AU - Reece, Lisa M.

AU - Hombach, Joachim

AU - Barrett, Alan

PY - 2016/7/28

Y1 - 2016/7/28

N2 - Zika virus (ZIKV) is a member of the family Flaviviridae, genus Flavivirus, and is transmitted by Aedes sp. mosquitoes. There are three genetic lineages of ZIKV: the East African, West African and Asian lineages. Until recently, Zika fever (ZF) has normally been considered a rare, mild febrile disease, but reports since 2012 have shown potentially severe complications associated with ZIKV infection, including microcephaly and Guillain-Barré syndrome. There are no licensed vaccines for ZIKV; however, many vaccine platforms/approaches that have been utilised for other flavivirus vaccines are being applied to ZIKV. Given the current outbreak of ZIKV in the Americas with its associated risks to pregnancy, we summarise what is known about the virus, how knowledge of currently licensed flavivirus vaccines can be applied to ZIKV vaccine development and the assessments of potential challenges for ZIKV vaccine testing and evaluation.

AB - Zika virus (ZIKV) is a member of the family Flaviviridae, genus Flavivirus, and is transmitted by Aedes sp. mosquitoes. There are three genetic lineages of ZIKV: the East African, West African and Asian lineages. Until recently, Zika fever (ZF) has normally been considered a rare, mild febrile disease, but reports since 2012 have shown potentially severe complications associated with ZIKV infection, including microcephaly and Guillain-Barré syndrome. There are no licensed vaccines for ZIKV; however, many vaccine platforms/approaches that have been utilised for other flavivirus vaccines are being applied to ZIKV. Given the current outbreak of ZIKV in the Americas with its associated risks to pregnancy, we summarise what is known about the virus, how knowledge of currently licensed flavivirus vaccines can be applied to ZIKV vaccine development and the assessments of potential challenges for ZIKV vaccine testing and evaluation.

UR - http://www.scopus.com/inward/record.url?scp=85015806084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015806084&partnerID=8YFLogxK

U2 - 10.1038/npjvaccines.2016.7

DO - 10.1038/npjvaccines.2016.7

M3 - Review article

VL - 1

JO - npj Vaccines

JF - npj Vaccines

SN - 2059-0105

M1 - 16007

ER -